This is an actively managed, exchange-quoted fund that invests in global equities using a long-short approach. That means the managers can buy shares they expect to rise (long positions) while also ...

Silver has surged as both a precious metal and an industrial input tied to solar power and electronics, and Australian investors have a direct way to hold it through Global X Physical Silver ...

The Betashares Climate Change Innovation ETF (ASX:ERTH) holds global companies whose products and services help address climate change, a theme that has swung between strong enthusiasm and sharp ...

Gold has powered to record levels as investors seek a Store of Value amid shifting rate expectations and geopolitical strain. Global X Gold Bullion ETF (ASX:GXLD) offers Australian investors direct, ...

This fund holds allocated physical gold, with each unit representing a claim on a set quantity of metal stored securely on investors' behalf. It aims to track the spot gold price, before fees, ...

Nuclear power has moved back into favour as governments weigh energy security and low-carbon electricity, and the VanEck Uranium and Nuclear ETF (ASX:URAN) offers a way to invest in the theme, ...

NEXTDC (ASX:NXT) has delivered a full-year result that reflects the continued build-out of its data centre capacity and a growing pipeline of contracted Demand from hyperscale, enterprise and ...

IGO reported FY2026 net profit after tax of $145.3 million, a significant turnaround from a $954.6 million loss in FY2025. The Greenbushes joint venture contributed $207 million in share of net profit ...

McMillan Shakespeare (ASX:MMS), one of Australia’s best-known salary-packaging and novated-leasing specialists, has brought its full-year performance into focus following the release of its FY26 ...

Mesoblast Limited (ASX:MSB) remained in investor focus within the Australian healthcare sector, with shares trading at AUD 2.42, up 0.21% or AUD 0.005 at the time of writing on 28 August 2026. The ...

Neuren Pharmaceuticals Limited (ASX:NEU) remained in focus within the Australian healthcare sector, with shares trading at AUD 20.37, down 3.09% or AUD 0.65 at the time of writing on 28 August 2026.

Clarity Pharmaceuticals Limited (ASX:CU6) remained in investor focus within the Australian healthcare sector, with shares trading at AUD 2.38, up 1.71% or AUD 0.040 at the time of writing on 28 August ...